Seongnam, South Korea · Founded 2018 · Privately Held (backing)
Developer of bacteria-mediated immunotherapy designed to treat tumors as well as cancer. LISCure Biosciences is based in Seongnam, South Korea and was founded in 2018. It has raised $47.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$47.5M
Last round
—
Cap table — not yet on record
LISCure Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of LISCure Biosciences with a free account
·The complete investor list: 18 names
·Watch LISCure Biosciences: the Monday email on marks, rounds and moves
